最新消息

GOVT SHOULD ACT EARLY TO BUY NEW COVID DRUG

標籤: pharmacists , Covid-19 , molnupiravir

2021 月 10 月 07 日

A pharmacists’ association said on Monday that a new drug for Covid-19 could help relieve the burden on hospitals if Hong Kong sees another outbreak of infections, adding that the government should act early to ensure the city is able to procure the medication.


The Society of Hospital Pharmacists of Hong Kong has welcomed the Hospital Authority’s plan to buy 500 courses of molnupiravir – the first oral antiviral medication for Covid-19 developed by a US drug maker.

Interim clinical trial results suggest the pills can cut the risk of hospitalisation by half.

Speaking on an RTHK programme, the society's president, William Chui, said although Hong Kong has had no local Covid cases for some time, it's a good idea for the government to approach the drug company early, as other countries are expected to compete for the new medication.

“This is a good start. I don’t think the government should wait and see because it would be too late as many countries already started to procure the new drug,” he said.

But University of Hong Kong microbiologist Ho Pak-leung said although the interim results were encouraging, trials for the drug were still incomplete.

He said the government should adopt a cautious approach and wait for more information on the drug.

Ho stressed that getting vaccinated was still the safest and most effective way to prevent complications and deaths arising from Covid-19.

 

 

[文章及圖片轉載RTHK 04/10/2021 連結]


分類文章標籤: pharmacists , Covid-19 , molnupiravir


其他相關文章

輝瑞研新藥服一粒可減重症 許樹...

2021 月 04 月 30 日

美國藥廠輝瑞(Pfizer)正研發治療COVID-19新口服藥物,是一種蛋白酶抑制劑,適用於感染初期,或可減低患者需入院...

【和你抗疫】酒精搓手液濃度勿超...

2020 月 03 月 06 日

新型冠狀病毒(COVID-19)肆虐,公眾對消毒用品需求大增,令市面上的酒精搓手液被一掃而空。有見及此,有專家及大學教授...

【新冠疫苗】默沙東新冠口服藥M...

2021 月 10 月 08 日

美國默沙東藥廠(Merck)上周五公布使用新型冠狀病毒口服藥Molnupiravir治療新冠患者的第三期臨牀研究中期數據...

更多
更多